By | March 29 2012 10:36 AM

Swiss drug and diagnostics company Roche Holding AG (FRA: RO) raised its offer Thursday for Illumina Inc. (Nasdaq: ILMN), a leading maker of gene-sequencing products, and warned that continued rejection could trigger a hostile-takeover bid.